Mucosal vaccination by adenoviruses displaying reovirus sigma 1

Eric A. Weaver, Zenaido T. Camacho, Matthew L. Hillestad, Catherine M. Crosby, Mallory A. Turner, Adam J. Guenzel, Hind J. Fadel, George T. Mercier, Michael A. Barry

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


We developed adenovirus serotype 5 (Ad5) vectors displaying the sigma 1 protein from reovirus as mucosal vaccines. Ad5-sigma retargets to JAM-1 and sialic acid, but has 40-fold reduced gene delivery when compared to Ad5. While weaker at transduction, Ad5-sigma generates stronger T cell responses than Ad5 when used for mucosal immunization. In this work, new Ad5-fiber-sigma vectors were generated by varying the number of fiber β-spiral shaft repeats (R) between the fiber tail and sigma. Increasing chimera length led to decreasing insertion of these proteinsAd5 virions. Ad-R3 and R14 vectors effectively targeted JAM-1 in vitro while R20 did not. When wereused to immunize mice by the intranasal route, Ad5-R3-sigma produced higher serum and vaginal antibody responses than Ad5. These data suggest optimized Ad-sigma vectors may be useful vectors for mucosal vaccination.

Original languageEnglish (US)
Pages (from-to)60-66
Number of pages7
StatePublished - Aug 1 2015


  • Adenovirus
  • Immunization
  • Mucosal
  • Reovirus
  • Sigma 1

ASJC Scopus subject areas

  • Virology


Dive into the research topics of 'Mucosal vaccination by adenoviruses displaying reovirus sigma 1'. Together they form a unique fingerprint.

Cite this